荃银高科(300087) - 2019 Q3 - 季度财报

Financial Position - Total assets at the end of the reporting period were CNY 1,761,843,916.77, a decrease of 7.57% compared to the end of the previous year[8]. - Net assets attributable to shareholders of the listed company were CNY 701,495,202.82, down 12.39% year-on-year[8]. - The total liabilities as of September 30, 2019, were ¥866,547,148.36, compared to ¥850,904,379.37 at the end of 2018, reflecting an increase of about 1.9%[51]. - The total equity attributable to shareholders decreased to ¥701,495,202.82 from ¥800,709,412.98, a decline of approximately 12.3%[54]. - The company's total assets increased to ¥1,084,804,173.63 from ¥1,064,925,406.34, marking a growth of approximately 1.7%[64]. - The total equity of the company decreased to ¥662,445,272.58 from ¥682,815,667.47, a decline of approximately 3%[64]. - The company reported accounts payable of approximately 94.88 million and prepayments of approximately 142.40 million[125]. - The company has a total of CNY 411,040,463.07 in accounts payable, which is important for understanding its short-term liabilities[115]. Revenue and Profitability - Operating revenue for the reporting period was CNY 102,141,541.71, an increase of 50.51% compared to the same period last year[8]. - Net profit attributable to shareholders of the listed company was a loss of CNY 24,642,886.20, a slight increase in loss of 1.85% year-on-year[8]. - Total operating revenue for the current period reached ¥102,141,541.71, a significant increase from ¥67,865,767.55 in the previous period, representing a growth of approximately 50.5%[65]. - Net profit for the current period was reported at -¥41,974,268.05, an improvement compared to -¥43,729,589.54 in the previous period, reflecting a reduction in losses[68]. - The total revenue for the current period is 111,659,109.59, up from 81,067,500.70 in the previous period, representing a growth of approximately 37.6%[91]. - The total profit for the current period is -56,375,663.96, an improvement from -67,340,254.03 in the previous period, reflecting better overall performance[86]. Cash Flow - The net cash flow from operating activities was CNY 74,870,930.04, a decrease of 56.33% compared to the same period last year[8]. - Cash inflow from operating activities totaled CNY 389,629,204.60, up from CNY 349,015,281.74 year-over-year[107]. - The net cash inflow from operating activities was CNY 74,870,930.04, a decrease of 56.3% compared to CNY 171,466,047.81 in the previous period[100]. - The cash paid for purchasing goods and services was CNY 79,169,094.90, slightly higher than CNY 74,102,676.87 in the previous period[107]. - The company reported a cash inflow of CNY 222,861,298.83 from other operating activities, compared to CNY 147,001,915.46 in the prior period[107]. Shareholder Information - The top shareholder, Sinochem Modern Agriculture Co., Ltd., held 21.50% of the shares, totaling 92,520,965 shares[12]. - The total number of ordinary shareholders at the end of the reporting period was 10,140[12]. - The company’s major shareholder, Ms. Zhang Qin, pledged 2.6 million and 1.2 million shares respectively[29]. Investments and Acquisitions - The company used its own funds of RMB 140.08 million to acquire 40% equity from minority shareholders of Qianyin Technology, making it a wholly-owned subsidiary[31]. - The company used its own funds of RMB 161.46 million to acquire 46% equity from minority shareholders of Wan Nong Seed Industry, making it a wholly-owned subsidiary[31]. - The company established a joint venture with a registered capital of CNY 10 million, holding a 53.2% stake[26]. - The company disposed of its 51% stake in Anhui Qianyin Gaosheng Investment Co., Ltd. to Anhui Zhonghe Hengfeng Agricultural Products Market Construction Management Co., Ltd.[26]. Operational Efficiency - The company adjusted its organizational structure to enhance operational efficiency[31]. - The company is focusing on expanding its market presence and enhancing product development, as indicated by the increase in development expenditures to ¥11,902,661.64 from ¥4,464,608.14[58]. - The company has reported a decrease in sales expenses to 27,556,261.48 from 25,565,727.92 in the previous period, indicating a more efficient cost management[91]. Research and Development - Research and development expenses for the current period were ¥13,165,710.81, up from ¥10,271,501.12, indicating an increase of about 28.5%[65]. - The research and development expenses for the current period are 7,989,278.57, down from 11,965,863.32 in the previous period, reflecting a decrease of about 33%[91]. - The company established a joint venture with research units for rice commercialization molecular breeding technology[36]. Government Support - The company received government subsidies amounting to CNY 6,124,860.02 during the reporting period[8].